摘要
目的:建立逆转录病毒介导入高迁移率族蛋白组A1(HMGA1)基因RNA干扰体外表达体系,并观察洛铂对脑胶质瘤细胞株SHG-44化疗敏感性的影响。方法:制备HMGA1 siRNA慢病毒载体,PCR筛选阳性克隆,测序鉴定;转染脑胶质瘤细胞株SHG-44后,RT-PCR检测其对细胞HMGA1基因表达的影响;MTT和克隆集落实验检测洛铂对阳性组和阴性组细胞生长、增殖的影响。结果:PCR和测序证实,成功构建HMGA1 siRNA的慢病毒载体;RT-PCR证实阳性组细胞存在HMGA1基因表达下调;分别用不同浓度的洛铂处理两组细胞24h后,MTT法和克隆集落实验显示阳性组细胞生长抑制率较阴性组细胞明显降低。结论:HMGA1 siRNA能特异性下调脑胶质瘤细胞SHG-44中HMGA1的表达并抑制了其对洛铂的敏感性。
Objective: To investigate the lobaplatin chemosensitivity change of brain glioma cells of SHG-44 after high mobility group A1 (HMGA1) inhibition by lentivirus-mediated RNA interference (RNAi). Methods: Lentiviral vectors of HMGAlsiRNA was constructed and verified by PCR and DNA sequencing; After transfected into the brain glioma cell line SHG-44 ,the expression of HMGA1 was determined by retrotranscriptase polymerase chain reaction(RT-PCR) ; The effect of lobaplatin on proliferation of positive and negative cells was observed by MTT assay and clonogenic survival assay. Results:PCR analysis and DNA sequencing demonstrated that the RNAi sequence targeting human HMGA1 gene was successfully inserted into the lentiviral vector; RT-PCR indicated that the expression of HMGA1 reduced obiviously in positive group. MTT assay and clonogenic survival assay showed that the inhibitory rate of positive group cells growth decreased significantly compared with negative group, treated with lobaplatin at different concentrations for 24h. Conclusion: RNAi vectors of HMGA1 could effectively suppress the expression of HMGA1 in SHG-44 cell line, and inhibit the sensitivity of brain glioma cells to lobaplatin.
出处
《临床肿瘤学杂志》
CAS
2009年第5期405-409,共5页
Chinese Clinical Oncology
基金
南京市医学发展重点项目(ZKX0427)
国家“863”攻关计划重大专项(2006020608)
全军医学科学技术研究“十一五”计划(06MA111)